首页> 外文期刊>Experimental Biology and Medicine: Journal of the Society for Experimental Biology and Medicine >A model of retinal ischemia-reperfusion injury in rats by subconjunctival injection of endothelin-1.
【24h】

A model of retinal ischemia-reperfusion injury in rats by subconjunctival injection of endothelin-1.

机译:结膜下注射内皮素-1大鼠视网膜缺血再灌注损伤模型。

获取原文
获取原文并翻译 | 示例
           

摘要

The retinal ischemia-reperfusion model is used in the study of transient ischemia-related diseases, such as central retinal artery occlusion, angle-closure glaucoma, and others. There are two methods for experimentally producing an ischemia-reperfusion model in the rat retina: (i) the intraocular pressure is greatly raised by increasing the height of the infusion bottle connected with the needle in the anterior chamber; or (ii) the blood vessel that accompanies the optic nerve in retina is ligated. However, each method has some drawbacks. For example, in the first method, the needle must be fixed in the anterior chamber for 1 hr, thus, the technique is not stable and mechanical damage to ocular structures sometimes occurs. In the second method, because of the unavoidable involvement of the optic nerve, damage to the nerve induces retinal changes unrelated to ischemia. In this study, we injected endothelin (ET)-1 under the conjunctiva of the eyeball (subconjunctival injection), and evaluated whether a retinal ischemia-reperfusion model could be generated by this method, simply and noninvasively. We injected 4 x 10(-5) M ET-1 solution into the right eye of the rat and injected a control vehicle (artificial tears) into the left eye. From 5-60 mins after the injection, 50 mg/ml fluorescein isothiocyanate (FITC)-dextran was injected to the left ventricle of heart. Then, the retina was removed and flat mounted. We compared the perfusion conditions of the FITC-dextran to each retina in the right and left eye. There was a complete perfusion of FITC-dextran in the retinal main artery, vein, and the capillary vessels in all of the control eyes. However, perfusion could not be completely observed in the ET-1 injected eye from 5-35 mins after injection; afterwards, the flow was returned. This method of subconjunctival injection of ET-1 is, thus, a feasible technical option for producing a retinal ischemia-reperfusion model in rat.
机译:视网膜缺血再灌注模型用于研究短暂性缺血相关疾病,例如视网膜中央动脉阻塞,闭角型青光眼等。有两种方法可以通过实验产生大鼠视网膜缺血再灌注模型:(i)通过增加与前房室针头相连的输液瓶的高度来大大提高眼内压;或(ii)结扎视网膜视神经所伴随的血管。但是,每种方法都有一些缺点。例如,在第一种方法中,必须将针头固定在前房中1个小时,因此,该技术不稳定,有时会发生对眼部结构的机械损伤。在第二种方法中,由于不可避免地会累及视神经,因此对神经的损伤会引起与缺血无关的视网膜变化。在这项研究中,我们在眼球结膜下注射了内皮素(ET)-1(结膜下注射),并评估了该方法是否可以简单,无创地产生视网膜缺血-再灌注模型。我们将4 x 10(-5)M ET-1溶液注入大鼠的右眼,并将对照载体(人工泪液)注入左眼。在注射后5-60分钟,将50mg / ml的异硫氰酸荧光素(FITC)-葡聚糖注射到心脏的左心室。然后,将视网膜切除并平坦安装。我们比较了FITC-葡聚糖对右眼和左眼每个视网膜的灌注情况。在所有对照眼中,视网膜主动脉,静脉和毛细血管中都完全充满了FITC-葡聚糖。然而,从注射后5-35分钟起,在注射了ET-1的眼中不能完全观察到灌注。之后,返回流程。因此,这种结膜下注射ET-1的方法是在大鼠中产生视网膜缺血-再灌注模型的可行技术选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号